3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
39
Leukemia
16
Congenital Abnormalities
10
Leukemia, Monocytic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Eosinophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Basophilic, Acute
2
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Interventions
ponatinib
4
pembrolizumab
3
Rituximab
3
Gemcitabine
3
Cyclophosphamide
3
130-nm albumin-bound paclitaxel
3
pralsetinib
2
napabucasin
2
Vincristine
2
Prednisone
2
Irinotecan
2
Imatinib Mesylate
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
Brentuximab Vedotin
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
ricolinostat
1
pomalidomide
1
pamiparib
1
nirogacestat
1
nilotinib
1
ibritumomab tiuxetan
1
denileukin diftitox
1
bosutinib
1
blinatumomab
1
Vorinostat
1
Temozolomide
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Histologic Type
×
Idarubicin
×
Clear all
No trials found.